Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…poor. The PERICLES study explored a novel strategy of combining atezolizumab with radiation therapy for patients with advanced PeCa. 65 Howe…
…rcinoma of the right lung, started treatment with cisplatin and pemetrexed. Two days after administration of chemotherapy, ischaemia of II…
…ng serplulimab with a taxane (paclitaxel or nab-paclitaxel) and carboplatin in patients with resectable stage II-IIIA sq-NSCLC.Methods This…
…tinum salts (carboplatin, oxaliplatin, cisplatin), and taxanes (paclitaxel, docetaxel).Methods This single-centre, retrospective study was…
…and poor prognosis. Adding immune checkpoint inhibitors such as pembrolizumab to neoadjuvant chemotherapy has improved pathological response …
…gical therapy (21%), and other (9%). Most implicated drugs were nivolumab, ipilimumab, carboplatin, paclitaxel, oxaliplatin, and pembroli…
…and sarcoma (0.9%). The most frequently desensitised drugs were paclitaxel (45.4%), oxaliplatin (24.5%), carboplatin (14.1%), docetaxel (9…
… and Obstetrics (FIGO) stage IVB). The patient was initiated on paclitaxel–carboplatin chemotherapy. This case highlights the diagnostic d…
…Background In Study 309/KEYNOTE-775 ( NCT03517449), lenvatinib+pembrolizumab versus chemotherapy significantly improved progre…
…agents showed the highest reporting disproportionality, notably dobutamine (reporting OR (ROR) (95% CI) 283.83 (226.55 to 355.60)) and nor…
…s with a history of breast cancer, undergoing chemotherapy with carboplatin and paclitaxel, is referred to the cardio-oncology clinic due t…
…ents and those treated with standard neoadjuvant HER2 therapies paclitaxel, with or without carboplatin, trastuzumab and pertuzumab (Taxol…